Conjugate Vaccine Companies

ID: MRFR/Pharma/2981-HCR

115 Pages

Rahul Gotadki

October 2025

Conjugate vaccines are a type of vaccine that consists of a combination of a bacterial or viral antigen and a carrier protein. These vaccines are designed to enhance the immune response, particularly in young children whose immune systems may not respond well to certain pathogens. Several pharmaceutical and biotechnology companies are engaged in the development and production of conjugate vaccines.

Conjugate Vaccines Market Research Report - Forecast till 2032 Infographic

Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Conjugate Vaccine Market

Conjugate vaccines Market

Latest Conjugate Vaccine Companies Updates:

Pfizer Announced a partnership with the Bill & Melinda Gates Foundation to develop and distribute a new conjugate vaccine for Group A Streptococcus (GAS) infections.

Merck & Co Launched their Gardasil 9 (human papillomavirus vaccine) in a single-dose format, aiming to improve vaccination rates among adolescents.

Serum Institute of India Expanded their manufacturing capacity for conjugate vaccines, solidifying their position as a major vaccine supplier in developing countries.

List of Conjugate Vaccine Key companies in the market:

GlaxoSmithKline plc.

Merck & Co., Inc. in the U.S

Fab life.in India

SutroVax Inc. In the U.S

Sanofi Pasteur SA. In France

Pfizer in the U.S

Sinovac Biotech Ltd. in China

IDT Biologics GmbH

GreenSignal Bio Pharma Limited in India

Taj Pharmaceuticals Limited in India

Bavarian Nordic in U.S